Global Cardiopulmonary Bypass Equipment Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Heart–Lung Machines, Oxygenators, Autotransfusion Systems, and Others

By Product Type;

Single Roller Pump and Double Roller Pump

By Application;

Cardiovascular, Respiratory, Hemodialysis, and Others

By End Users;

Hospitals and Ambulatory Surgical Centers

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn530847204 Published Date: May, 2025 Updated Date: July, 2025

Cardiopulmonary Bypass Equipment Market Overview

Cardiopulmonary Bypass Equipment Market (USD Million)

Cardiopulmonary Bypass Equipment Market was valued at USD 2,033.33 million in the year 2024. The size of this market is expected to increase to USD 2,946.09 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.4%.


Global Cardiopulmonary Bypass Equipment Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 5.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)5.4 %
Market Size (2024)USD 2,033.33 Million
Market Size (2031)USD 2,946.09 Million
Market ConcentrationMedium
Report Pages371
2,033.33
2024
2,946.09
2031

Major Players

  • Medtronic plc
  • LivaNova PLC
  • Terumo Corporation
  • Getinge AB
  • Braile Biomedica
  • Sorin Group
  • Maquet (a subsidiary of Getinge AB)
  • Xenios AG
  • MicroPort Scientific Corporation
  • SynCardia Systems, LLC

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Cardiopulmonary Bypass Equipment Market

Fragmented - Highly competitive market without dominant players


The Cardiopulmonary Bypass Equipment Market is growing steadily as the number of heart surgeries continues to rise. These systems are vital for procedures like heart transplants and bypass grafting, where blood flow must be maintained externally. More than 55% of major heart operations now depend on these devices, underlining their critical role in modern surgical care.

Innovations Enhancing Clinical Outcomes
Advances in bypass system technologies, such as improved oxygenators and compact pump designs, are significantly improving surgical safety. These innovations have contributed to a 40% increase in successful procedural outcomes. Real-time monitoring and data integration features are also making the systems more reliable and precise for use during critical interventions.

Increasing Prevalence of Cardiopulmonary Disorders
As cardiac and respiratory disorders continue to rise, the use of bypass systems in surgeries is increasing. These devices are involved in over 60% of complex surgical procedures that require temporary heart or lung support, highlighting their vital function in critical care environments.

Infrastructure and Policy Support for Adoption
Enhanced healthcare funding and a focus on upgrading surgical facilities are contributing to broader adoption. Approximately 45% of advanced care hospitals now use high-performance bypass equipment, driven by the need for precision and improved patient care standards.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Product Type
    3. Market Snapshot, By Application
    4. Market Snapshot, By End Users
    5. Market Snapshot, By Region
  4. Cardiopulmonary Bypass Equipment Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of cardiovascular diseases
        2. Technological advancements
        3. Growing demand for minimally invasive procedures
        4. Rising healthcare expenditure
      2. Restraints
        1. High cost of equipment
        2. Stringent regulatory requirements
        3. Complications associated with bypass procedures
        4. Limited reimbursement policies
        5. Alternatives to bypass surgery
      3. Opportunities
        1. Development of hybrid operating rooms
        2. Focus on product innovation
        3. Collaborations and partnerships
        4. Increasing awareness and education
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Cardiopulmonary Bypass Equipment Market, By Product , 2021 - 2031 (USD Million)
      1. Heart–Lung Machines
      2. Oxygenators
      3. Autotransfusion Systems
      4. Others
    2. Cardiopulmonary Bypass Equipment Market, By Product Type, 2021 - 2031 (USD Million)
      1. Single Roller Pump
      2. Double Roller Pump
    3. Cardiopulmonary Bypass Equipment Market, By Application, 2021 - 2031 (USD Million)
      1. Cardiovascular
      2. Respiratory
      3. Hemodialysis
      4. Others
    4. Cardiopulmonary Bypass Equipment Market, By End Users, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Ambulatory Surgical Centers
    5. Cardiopulmonary Bypass Equipment Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic plc
      2. LivaNova PLC
      3. Terumo Corporation
      4. Getinge AB
      5. Braile Biomedica
      6. Sorin Group
      7. Maquet (a subsidiary of Getinge AB)
      8. Xenios AG
      9. MicroPort Scientific Corporation
      10. SynCardia Systems, LLC
  7. Analyst Views
  8. Future Outlook of the Market